Inventor
Bryan LEMON
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides36%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture7%
PatentTitleYear
12,516,128EpCAM binding proteins and methods of use202612,441,796Antibody constructs for CDH19 and CD3202511,739,131Growth differentiation factor 15 (GDF-15) polypeptides202311,623,958Single chain variable fragment CD3 binding proteins202311,498,964Antibody constructs for CDH19 and CD32022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to AMGEN INC (3)· patent assignee history
2022–2025Patents assigned to AMGEN RES MUNICH GMBH (2)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to HARPOON THERAPEUTICS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 3 | 2022–2025 |
| AMGEN RES MUNICH GMBH | 2 | 2022–2025 |
| HARPOON THERAPEUTICS INC | 2 | 2023–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2026 |